HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J L Frater Selected Research

Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)

3/2011High resolution array comparative genomic hybridization identifies copy number alterations in diffuse large B-cell lymphoma that predict response to immuno-chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J L Frater Research Topics

Disease

2Lymphoma (Lymphomas)
03/2011 - 12/2001
1Obesity
01/2022
1Myeloid Sarcoma (Chloroma)
12/2011
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2011
1Neoplasms (Cancer)
03/2011

Drug/Important Bio-Agent (IBA)

14-bromobenzoyl-(alpha-aminoisobutyric acid)(5)-leucyl-(alpha-aminoisobutyric acid)(2)-methoxy (BALA)IBA
01/2022
1Muramidase (Lysozyme)IBA
12/2011
1Biomarkers (Surrogate Marker)IBA
03/2011
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
03/2011
1EnzymesIBA
03/2011
1Biological ProductsIBA
12/2001

Therapy/Procedure

1Drug Therapy (Chemotherapy)
03/2011
1Therapeutics
03/2011